Ephicacy

Established in 2005 with headquarters in Jersey City, New Jersey, US, Ephicacy was founded with the singular objective of being a niche provider of consultancy.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

PHARMACY MARKET

VIRPAX PHARMACEUTICALS RECAPS MILESTONES AND HIGHLIGHTS PRODUCT PORTFOLIO

Virpax® Pharmaceuticals, Inc. | December 29, 2021

news image

Virpax® Pharmaceuticals, Inc. "Company" achieved significant milestones relating to its pipeline of product candidates as of the end of 2021, which are summarized below. “I believe that Virpax has made significant progress this past year toward our stated goalsThese accomplishments include accelerated development of our existing product candidates, broadening our pipeline of product candidates, and utilizing grants where appropriate. We recently...

Read More

TACKLING THE INNOVATION CRISIS IN DRUG DISCOVERY AND DEVELOPMENT

Technology Networks | February 17, 2020

news image

Arctoris Ltd has announced a formal partnership with Molecule in order to tackle the ongoing innovation crisis faced by drug discovery and development across both industry and academia. Through its fully automated drug discovery platform, Arctoris aims to enable researchers and biotechnological entrepreneurs to design and remotely execute advanced cell-based, molecular biology and biochemical assays. Together with Molecule’s distributed IP ownership platform, which enables stakeholders in ...

Read More

PHARMACY MARKET

INSILICO MEDICINE ANNOUNCED STRATEGIC COLLABORATION WITH EQRX

Insilico Medicine | March 25, 2022

news image

A clinical-stage end-to-end artificial intelligence driven drug discovery firm, Insilico Medicine announced the formation of a strategic partnership with EQRx, a company dedicated to creating and delivering novel medications to patients at much-reduced costs. The cooperation will use Insilico's Pharma.AI technology to accelerate the design and creation of de novo small molecules and EQRx's clinical development and commercialization experience. In addition, EQRx and Insilic...

Read More

BUSINESS INSIGHTS

TO PROVIDE SUITE OF CLINICAL TRIAL TECHNOLOGIES AND SERVICES, LABCORP RENEWED STRATEGIC PARTNERSHIP WITH MEDIDATA

Medidata | April 01, 2022

news image

A Dassault Systèmes company, Medidata, announced that Labcorp, a leading global life sciences company, has extended its 14-year partnership with Medidata, laying the groundwork for their initiative to co-develop digital biomarkers and expand the use and functionality of decentralized clinical trials. “Our relationship with Medidata is built on using their core technologies to enhance our clinical trial portfolio and continue to expand our decentr...

Read More
news image

PHARMACY MARKET

VIRPAX PHARMACEUTICALS RECAPS MILESTONES AND HIGHLIGHTS PRODUCT PORTFOLIO

Virpax® Pharmaceuticals, Inc. | December 29, 2021

Virpax® Pharmaceuticals, Inc. "Company" achieved significant milestones relating to its pipeline of product candidates as of the end of 2021, which are summarized below. “I believe that Virpax has made significant progress this past year toward our stated goalsThese accomplishments include accelerated development of our existing product candidates, broadening our pipeline of product candidates, and utilizing grants where appropriate. We recently...

Read More
news image

TACKLING THE INNOVATION CRISIS IN DRUG DISCOVERY AND DEVELOPMENT

Technology Networks | February 17, 2020

Arctoris Ltd has announced a formal partnership with Molecule in order to tackle the ongoing innovation crisis faced by drug discovery and development across both industry and academia. Through its fully automated drug discovery platform, Arctoris aims to enable researchers and biotechnological entrepreneurs to design and remotely execute advanced cell-based, molecular biology and biochemical assays. Together with Molecule’s distributed IP ownership platform, which enables stakeholders in ...

Read More
news image

PHARMACY MARKET

INSILICO MEDICINE ANNOUNCED STRATEGIC COLLABORATION WITH EQRX

Insilico Medicine | March 25, 2022

A clinical-stage end-to-end artificial intelligence driven drug discovery firm, Insilico Medicine announced the formation of a strategic partnership with EQRx, a company dedicated to creating and delivering novel medications to patients at much-reduced costs. The cooperation will use Insilico's Pharma.AI technology to accelerate the design and creation of de novo small molecules and EQRx's clinical development and commercialization experience. In addition, EQRx and Insilic...

Read More
news image

BUSINESS INSIGHTS

TO PROVIDE SUITE OF CLINICAL TRIAL TECHNOLOGIES AND SERVICES, LABCORP RENEWED STRATEGIC PARTNERSHIP WITH MEDIDATA

Medidata | April 01, 2022

A Dassault Systèmes company, Medidata, announced that Labcorp, a leading global life sciences company, has extended its 14-year partnership with Medidata, laying the groundwork for their initiative to co-develop digital biomarkers and expand the use and functionality of decentralized clinical trials. “Our relationship with Medidata is built on using their core technologies to enhance our clinical trial portfolio and continue to expand our decentr...

Read More